Repligen Corp. (RGEN)
180.98
+4.71
(+2.67%)
USD |
NASDAQ |
Aug 31, 16:00
180.94
-0.04
(-0.02%)
After-Hours: 07:22
Repligen Cash from Operations (Annual) : 117.42M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 117.42M |
| December 31, 2024 | 175.39M |
| December 31, 2023 | 113.92M |
| December 31, 2022 | 172.08M |
| December 31, 2021 | 119.02M |
| December 31, 2020 | 62.62M |
| December 31, 2019 | 67.22M |
| December 31, 2018 | 32.77M |
| December 31, 2017 | 17.45M |
| December 31, 2016 | 7.521M |
| December 31, 2015 | 15.05M |
| December 31, 2014 | 18.40M |
| December 31, 2013 | 25.93M |
| December 31, 2012 | 13.44M |
| December 31, 2011 | 2.311M |
| March 31, 2011 | |
| March 31, 2010 | -2.448M |
| Date | Value |
|---|---|
| March 31, 2009 | 6.307M |
| March 31, 2008 | 38.47M |
| March 31, 2007 | 0.4055M |
| March 31, 2006 | 0.4154M |
| March 31, 2005 | -0.7953M |
| March 31, 2004 | -5.718M |
| March 31, 2003 | -5.258M |
| March 31, 2002 | -4.754M |
| March 31, 2001 | -4.62M |
| March 31, 2000 | -3.134M |
| March 31, 1999 | -1.222M |
| March 31, 1998 | -0.7242M |
| March 31, 1997 | -3.237M |
| March 31, 1996 | -9.303M |
| March 31, 1995 | -14.62M |
| March 31, 1994 | -24.81M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| BioLife Solutions, Inc. | 20.12M |
| Danaher Corp. | 6.416B |
| Liquidia Corp. | -35.69M |
| Harmony Biosciences Holdings, Inc. | 348.20M |
| Agilent Technologies, Inc. | 1.559B |